Report Detail

Pharma & Healthcare Global Herpes Simplex Virus (HSV) Vaccines Market Research Report 2020

  • RnM4248893
  • |
  • 12 November, 2020
  • |
  • Global
  • |
  • 91 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

1 Herpes Simplex Virus (HSV) Vaccines Market Overview

  • 1.1 Product Overview and Scope of Herpes Simplex Virus (HSV) Vaccines
  • 1.2 Herpes Simplex Virus (HSV) Vaccines Segment by Type
    • 1.2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Growth Rate Comparison by Type (2021-2026)
    • 1.2.2 GEN-003
    • 1.2.3 VCL-HB01
    • 1.2.4 HSV529
    • 1.2.5 Others
  • 1.3 Herpes Simplex Virus (HSV) Vaccines Segment by Application
    • 1.3.1 Herpes Simplex Virus (HSV) Vaccines Sales Comparison by Application: 2020 VS 2026
    • 1.3.2 HSV-1 (Oral Herpes)
    • 1.3.3 HSV-2 (Genital Herpes)
  • 1.4 Global Herpes Simplex Virus (HSV) Vaccines Market Size Estimates and Forecasts
    • 1.4.1 Global Herpes Simplex Virus (HSV) Vaccines Revenue 2015-2026
    • 1.4.2 Global Herpes Simplex Virus (HSV) Vaccines Sales 2015-2026
    • 1.4.3 Herpes Simplex Virus (HSV) Vaccines Market Size by Region: 2020 Versus 2026
  • 1.5 Herpes Simplex Virus (HSV) Vaccines Industry
  • 1.6 Herpes Simplex Virus (HSV) Vaccines Market Trends

2 Global Herpes Simplex Virus (HSV) Vaccines Market Competition by Manufacturers

  • 2.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global Herpes Simplex Virus (HSV) Vaccines Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers Herpes Simplex Virus (HSV) Vaccines Manufacturing Sites, Area Served, Product Type
  • 2.5 Herpes Simplex Virus (HSV) Vaccines Market Competitive Situation and Trends
    • 2.5.1 Herpes Simplex Virus (HSV) Vaccines Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key Herpes Simplex Virus (HSV) Vaccines Players (Opinion Leaders)

3 Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario by Region

  • 3.1 Global Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global Herpes Simplex Virus (HSV) Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
    • 3.3.1 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.3.2 North America Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
    • 3.4.1 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.4.2 Europe Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region
    • 3.5.2 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
    • 3.6.1 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.6.2 Latin America Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.6.3 Mexico
    • 3.6.3 Brazil
    • 3.6.3 Argentina
  • 3.7 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.7.2 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Analysis by Type

  • 4.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Type (2015-2020)
  • 4.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Type (2015-2020)
  • 4.3 Global Herpes Simplex Virus (HSV) Vaccines Price Market Share by Type (2015-2020)
  • 4.4 Global Herpes Simplex Virus (HSV) Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Herpes Simplex Virus (HSV) Vaccines Historic Market Analysis by Application

  • 5.1 Global Herpes Simplex Virus (HSV) Vaccines Sales Market Share by Application (2015-2020)
  • 5.2 Global Herpes Simplex Virus (HSV) Vaccines Revenue Market Share by Application (2015-2020)
  • 5.3 Global Herpes Simplex Virus (HSV) Vaccines Price by Application (2015-2020)

6 Company Profiles and Key Figures in Herpes Simplex Virus (HSV) Vaccines Business

  • 6.1 Sanofi
    • 6.1.1 Corporation Information
    • 6.1.2 Sanofi Description, Business Overview and Total Revenue
    • 6.1.3 Sanofi Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 Sanofi Products Offered
    • 6.1.5 Sanofi Recent Development
  • 6.2 GlaxoSmithKline
    • 6.2.1 GlaxoSmithKline Corporation Information
    • 6.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue
    • 6.2.3 GlaxoSmithKline Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 GlaxoSmithKline Products Offered
    • 6.2.5 GlaxoSmithKline Recent Development
  • 6.3 Genocea Biosciences
    • 6.3.1 Genocea Biosciences Corporation Information
    • 6.3.2 Genocea Biosciences Description, Business Overview and Total Revenue
    • 6.3.3 Genocea Biosciences Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 Genocea Biosciences Products Offered
    • 6.3.5 Genocea Biosciences Recent Development
  • 6.4 Vical
    • 6.4.1 Vical Corporation Information
    • 6.4.2 Vical Description, Business Overview and Total Revenue
    • 6.4.3 Vical Herpes Simplex Virus (HSV) Vaccines Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Vical Products Offered
    • 6.4.5 Vical Recent Development

7 Herpes Simplex Virus (HSV) Vaccines Manufacturing Cost Analysis

  • 7.1 Herpes Simplex Virus (HSV) Vaccines Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Herpes Simplex Virus (HSV) Vaccines
  • 7.4 Herpes Simplex Virus (HSV) Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Herpes Simplex Virus (HSV) Vaccines Distributors List
  • 8.3 Herpes Simplex Virus (HSV) Vaccines Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global Herpes Simplex Virus (HSV) Vaccines Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Herpes Simplex Virus (HSV) Vaccines by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of Herpes Simplex Virus (HSV) Vaccines by Type (2021-2026)
  • 10.2 Herpes Simplex Virus (HSV) Vaccines Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Herpes Simplex Virus (HSV) Vaccines by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of Herpes Simplex Virus (HSV) Vaccines by Application (2021-2026)
  • 10.3 Herpes Simplex Virus (HSV) Vaccines Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Herpes Simplex Virus (HSV) Vaccines by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of Herpes Simplex Virus (HSV) Vaccines by Region (2021-2026)
  • 10.4 North America Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2021-2026)
  • 10.5 Europe Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2021-2026)
  • 10.6 Asia Pacific Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2021-2026)
  • 10.7 Latin America Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2021-2026)
  • 10.8 Middle East and Africa Herpes Simplex Virus (HSV) Vaccines Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type, the Herpes Simplex Virus (HSV) Vaccines market is segmented into
    GEN-003
    VCL-HB01
    HSV529
    Others

    Segment by Application
    HSV-1 (Oral Herpes)
    HSV-2 (Genital Herpes)

    Global Herpes Simplex Virus (HSV) Vaccines Market: Regional Analysis
    The Herpes Simplex Virus (HSV) Vaccines market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
    The key regions covered in the Herpes Simplex Virus (HSV) Vaccines market report are:
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    Global Herpes Simplex Virus (HSV) Vaccines Market: Competitive Analysis
    This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

    The major players in global Herpes Simplex Virus (HSV) Vaccines market include:
    Sanofi
    GlaxoSmithKline
    Genocea Biosciences
    Vical


    Summary:
    Get latest Market Research Reports on Herpes Simplex Virus (HSV) Vaccines. Industry analysis & Market Report on Herpes Simplex Virus (HSV) Vaccines is a syndicated market report, published as Global Herpes Simplex Virus (HSV) Vaccines Market Research Report 2020. It is complete Research Study and Industry Analysis of Herpes Simplex Virus (HSV) Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,173.87
    3,260.80
    4,347.74
    2,442.79
    3,664.19
    4,885.59
    302,954.30
    454,431.45
    605,908.60
    214,790.24
    322,185.36
    429,580.48
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report